398 related articles for article (PubMed ID: 20308632)
1. The effector T cell response to ryegrass pollen is counterregulated by simultaneous induction of regulatory T cells.
Mittag D; Scholzen A; Varese N; Baxter L; Paukovics G; Harrison LC; Rolland JM; O'Hehir RE
J Immunol; 2010 May; 184(9):4708-16. PubMed ID: 20308632
[TBL] [Abstract][Full Text] [Related]
2. TLR ligands of ryegrass pollen microbial contaminants enhance Th1 and Th2 responses and decrease induction of Foxp3(hi) regulatory T cells.
Mittag D; Varese N; Scholzen A; Mansell A; Barker G; Rice G; Rolland JM; O'Hehir RE
Eur J Immunol; 2013 Mar; 43(3):723-33. PubMed ID: 23238878
[TBL] [Abstract][Full Text] [Related]
3. Depletion of CD4+CD25+CD127lo regulatory T cells does not increase allergen-driven T cell activation.
Skrindo I; Farkas L; Kvale EO; Johansen FE; Jahnsen FL
Clin Exp Allergy; 2008 Nov; 38(11):1752-9. PubMed ID: 18681851
[TBL] [Abstract][Full Text] [Related]
4. Immune regulation by CD4+CD25+ T cells and interleukin-10 in birch pollen-allergic patients and non-allergic controls.
Thunberg S; Akdis M; Akdis CA; Grönneberg R; Malmström V; Trollmo C; van Hage M; Gafvelin G
Clin Exp Allergy; 2007 Aug; 37(8):1127-36. PubMed ID: 17651141
[TBL] [Abstract][Full Text] [Related]
5. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
Huang H; Dawicki W; Zhang X; Town J; Gordon JR
J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
[TBL] [Abstract][Full Text] [Related]
6. Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.
Wang LH; Lin YH; Yang J; Guo W
Int Arch Allergy Immunol; 2009; 148(3):199-210. PubMed ID: 18849611
[TBL] [Abstract][Full Text] [Related]
7. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season.
Grindebacke H; Wing K; Andersson AC; Suri-Payer E; Rak S; Rudin A
Clin Exp Allergy; 2004 Sep; 34(9):1364-72. PubMed ID: 15347368
[TBL] [Abstract][Full Text] [Related]
8. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
9. Regulatory activity of human CD4 CD25 T cells depends on allergen concentration, type of allergen and atopy status of the donor.
Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
Immunology; 2005 Sep; 116(1):103-11. PubMed ID: 16108822
[TBL] [Abstract][Full Text] [Related]
10. Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barré syndrome.
Chi LJ; Wang HB; Zhang Y; Wang WZ
J Neuroimmunol; 2007 Dec; 192(1-2):206-14. PubMed ID: 17997492
[TBL] [Abstract][Full Text] [Related]
11. Suppression of allergic inflammation by allergen-DNA-modified dendritic cells depends on the induction of Foxp3+ Regulatory T cells.
Wu K; Bi Y; Sun K; Xia J; Wang Y; Wang C
Scand J Immunol; 2008 Feb; 67(2):140-51. PubMed ID: 18201369
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells and asthma.
Robinson DS
Clin Exp Allergy; 2009 Sep; 39(9):1314-23. PubMed ID: 19538496
[TBL] [Abstract][Full Text] [Related]
13. Children with egg allergy have evidence of reduced neonatal CD4(+)CD25(+)CD127(lo/-) regulatory T cell function.
Smith M; Tourigny MR; Noakes P; Thornton CA; Tulic MK; Prescott SL
J Allergy Clin Immunol; 2008 Jun; 121(6):1460-6, 1466.e1-7. PubMed ID: 18455222
[TBL] [Abstract][Full Text] [Related]
14. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
[TBL] [Abstract][Full Text] [Related]
15. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.
Bohle B; Kinaciyan T; Gerstmayr M; Radakovics A; Jahn-Schmid B; Ebner C
J Allergy Clin Immunol; 2007 Sep; 120(3):707-13. PubMed ID: 17681368
[TBL] [Abstract][Full Text] [Related]
16. Allergen-specific IL-10-secreting type I T regulatory cells, but not CD4(+)CD25(+)Foxp3(+) T cells, are decreased in peripheral blood of patients with persistent allergic rhinitis.
Han D; Wang C; Lou W; Gu Y; Wang Y; Zhang L
Clin Immunol; 2010 Aug; 136(2):292-301. PubMed ID: 20403730
[TBL] [Abstract][Full Text] [Related]
17. Superantigen-induced proliferation of human CD4+CD25- T cells is followed by a switch to a functional regulatory phenotype.
Taylor AL; Llewelyn MJ
J Immunol; 2010 Dec; 185(11):6591-8. PubMed ID: 21048104
[TBL] [Abstract][Full Text] [Related]
18. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
19. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
[TBL] [Abstract][Full Text] [Related]
20. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]